Human services

Seniors Helping Seniors® In-Home Care Services Expands to North Houston

Retrieved on: 
Friday, March 29, 2024

HOUSTON, March 29, 2024 /PRNewswire-PRWeb/ -- Seniors Helping Seniors® in-home care services, a franchisor with over 125 franchise partners and more than 200 territories nationwide, has grown rapidly in recent years by building a workforce of talented caregivers who create meaningful relationships with their senior care clients. Now, local resident Roderick Woodworth III has opened a new location to serve the north Houston community.

Key Points: 
  • HOUSTON, March 29, 2024 /PRNewswire-PRWeb/ -- Seniors Helping Seniors® in-home care services, a franchisor with over 125 franchise partners and more than 200 territories nationwide, has grown rapidly in recent years by building a workforce of talented caregivers who create meaningful relationships with their senior care clients.
  • When he found himself in a position to seek a new career opportunity, he decided to venture into franchising with Seniors Helping Seniors to serve in his North Houston community.
  • Seniors Helping Seniors® services is expanding in Texas with its unique care services and approach to caregiver-client matching.
  • This new location in North Houston will mark the fourteenth in the state and will focus on serving the communities within North Houston.

Walk Your Way to Better Health

Retrieved on: 
Tuesday, March 26, 2024

Regular exercise improves mood, boosts energy and can even help you sleep better.

Key Points: 
  • Regular exercise improves mood, boosts energy and can even help you sleep better.
  • Get moving to reduce your stress and step into better health.
  • A little creativity can go a long way to make your walk more fun.
  • If you work remotely, take a conference call on the go or plan your walk as a reward for completing a project.

Casebook PBC Survey Finds Nonprofits Using Case Management Software Reduced Time Spent on Program Audits by 66%

Retrieved on: 
Tuesday, March 26, 2024

NEW YORK, March 26, 2024 /PRNewswire-PRWeb/ -- Today, Casebook PBC, the innovator of human services software, is revealing new insights from a survey of nearly 30 nonprofit leaders from organizations across child and family services, mental health, substance abuse, senior care, community services and more. The study examined challenges and insights from human services organizations with less than 50 employees and shows that 60% still use spreadsheets for tracking and reporting, while nearly four in 10 use paper records for intake, case management, and outcome analysis.

Key Points: 
  • The Casebook PBC survey shows that a majority of nonprofits are not using data for decision-making because it is difficult to collect - and if they are, they're using multiple platforms.
  • The Casebook PBC survey shows that a majority of nonprofits are not using data for decision-making because it is difficult to collect - and if they are, they're using multiple platforms.
  • At the same time, organizations that have deployed case management software are spending less than four hours per program audit - a reduction of nearly 66% compared to those without software.
  • Choose the Right Case Management Software: Configurable case management software, such as Casebook, lets you achieve more in a faster, more client-focused workflow.

FDA Roundup: March 22, 2024

Retrieved on: 
Friday, March 22, 2024

On Thursday, the FDA updated the Breakthrough Devices Program webpage to update the device designations data and the marketing authorizations list.

Key Points: 
  • On Thursday, the FDA updated the Breakthrough Devices Program webpage to update the device designations data and the marketing authorizations list.
  • From launch of the Breakthrough Devices Program through December 31, 2023, in total, the FDA granted 933 Breakthrough Devices designations and authorized 95 Breakthrough Devices for marketing.
  • On Thursday, the FDA approved safety labeling changes for fluorouracil injection products.
  • These changes also enable the FDA to more effectively respond to new information on the safety and use of food contact substances.

American Foundation for Suicide Prevention Applauds Bipartisan Effort to Improve 988 Suicide & Crisis Lifeline

Retrieved on: 
Friday, March 22, 2024

WASHINGTON, March 22, 2024 /PRNewswire/ -- Yesterday, the Federal Communications Commission Chairwoman Jessica Rosenworcel shared an important new proposal to improve access to services through the 988 Suicide & Crisis Lifeline.

Key Points: 
  • WASHINGTON, March 22, 2024 /PRNewswire/ -- Yesterday, the Federal Communications Commission Chairwoman Jessica Rosenworcel shared an important new proposal to improve access to services through the 988 Suicide & Crisis Lifeline.
  • "The American Foundation for Suicide Prevention applauds Chairwoman Rosenworcel, Secretary Becerra, Senator Tillis, Senator Padilla, and Representative Cárdenas for their collaboration and commitment to improving access to the 988 Lifeline," said Laurel Stine, J.D., M.A , Executive Vice President and Chief Policy Officer for AFSP.
  • AFSP is heartened to see the collaboration of bipartisan Congressional leaders and the FCC to build up the 988 Lifeline to be as robust and effective as it can be.
  • The American Foundation for Suicide Prevention is the nation's largest non-profit dedicated to saving lives and bringing hope to those affected by suicide.

FDA Approves Nonsteroidal Treatment for Duchenne Muscular Dystrophy

Retrieved on: 
Thursday, March 21, 2024

SILVER SPRING, Md., March 21, 2024 /PRNewswire/ -- Today, the U.S. Food and Drug Administration approved Duvyzat (givinostat) oral medication for the treatment of Duchenne Muscular Dystrophy (DMD) in patients six years of age and older.

Key Points: 
  • SILVER SPRING, Md., March 21, 2024 /PRNewswire/ -- Today, the U.S. Food and Drug Administration approved Duvyzat (givinostat) oral medication for the treatment of Duchenne Muscular Dystrophy (DMD) in patients six years of age and older.
  • Duvyzat is the first nonsteroidal drug approved to treat patients with all genetic variants of DMD.
  • "This approval provides another treatment option to help reduce the burden of this progressive, devastating disease for individuals impacted by DMD regardless of genetic mutation."
  • DMD is the most common childhood form of muscular dystrophy and typically affects males.

Behavioral Health Industry Experts Join Oceans Healthcare's Board of Directors

Retrieved on: 
Thursday, March 21, 2024

PLANO, Texas, March 21, 2024 /PRNewswire/ -- Oceans Healthcare has announced the addition of highly regarded Harvard Medical School psychiatry professor Dr. Michael Jellinek and decorated public health executive Dr. Courtney Phillips to its Board of Directors. These additions underscore the growing behavioral health organization's commitment to advancing healing and long-term recovery through patient-centered behavioral health care.

Key Points: 
  • These additions underscore the growing behavioral health organization's commitment to advancing healing and long-term recovery through patient-centered behavioral health care.
  • "Our nation's behavioral health crisis demands leaders with a breadth of knowledge and unwavering compassion," said Oceans Healthcare CEO Stuart Archer.
  • "Effective communication, alongside advocating for legislation that supports patients and health care providers, is crucial in informing stakeholders about the intricate nature and continuum of behavioral health services," Phillips emphasized.
  • Through acquisitions, high-profile joint ventures, new facility development and the addition of new services, Oceans has grown 300% since 2014.

SureCo Helps Large Employers Adopt New Benefits Model With First-Ever ICHRA Compliance eBook

Retrieved on: 
Wednesday, March 20, 2024

With the release of its ebook, "ICHRA Compliance: The Definitive Guide for Large Employers," SureCo aims to empower businesses with over 150 employees with the knowledge and tools they need to understand the ACA's Employer Mandate and avoid common compliance pitfalls that can trigger millions of dollars worth of penalty fines from the IRS.

Key Points: 
  • With the release of its ebook, "ICHRA Compliance: The Definitive Guide for Large Employers," SureCo aims to empower businesses with over 150 employees with the knowledge and tools they need to understand the ACA's Employer Mandate and avoid common compliance pitfalls that can trigger millions of dollars worth of penalty fines from the IRS.
  • This free resource is the first of its kind, offering comprehensive guidance on Individual Coverage Health Reimbursement Arrangement (ICHRA) compliance.
  • "The health insurance market is shifting, and we're at an inflection point for ICHRA adoption," says SureCo CEO and Co-Founder Matthew Kim.
  • The eBook concludes with a 2024 ICHRA Compliance Checklist, providing employers with a practical tool for ongoing compliance.

KCU awarded a total of $16 million to build Center for Population Health and Equity

Retrieved on: 
Wednesday, March 20, 2024

The foundation awarded KCU a $5 million grant to assist in the construction and capital improvements of buildings that will house the Center on both campuses.

Key Points: 
  • The foundation awarded KCU a $5 million grant to assist in the construction and capital improvements of buildings that will house the Center on both campuses.
  • "KCU's Center for Population Health and Equity is exactly the commitment our communities require to explore the root causes and systems that create inequitable outcomes and create solutions to build more equitable and just communities."
  • "I am certain that now is the time for a concerted focus on population health and equity.
  • KCU will anchor population health and health equity in curricula across all its academic programs in osteopathic medicine, biomedical sciences, clinical psychology and dental medicine.

Enhancing National Preparedness: Rafa Laboratories Partners with BARDA to Advance the Development of a new design for Rafa's Pediatric Atropine Autoinjectors

Retrieved on: 
Wednesday, March 20, 2024

Atropine - the primary antidote for nerve agent and insecticide poisoning, is usually administered via autoinjectors.

Key Points: 
  • Atropine - the primary antidote for nerve agent and insecticide poisoning, is usually administered via autoinjectors.
  • Rafa Laboratories already manufactures adult atropine autoinjectors, FDA-approved in July 2018, and pediatric atropine autoinjectors authorized for use under FDA Emergency Use Authorization (EUA) in January 2018.
  • The new design for the pediatric atropine autoinjector, which is intended for civilian use, will incorporate a new needle shield mechanism feature.
  • To meet FDA approval requirements for the enhanced pediatric atropine autoinjector, BARDA will provide comprehensive support to Rafa Laboratories.